Valuation: Edwards Lifesciences Corporation

Market Cap 60.51B 55.13B 51.03B 46.16B 86.59B 5,651B 90.63B 617B 245B 3,054B 227B 222B 9,673B P/E 2026 *
44.8x
P/E 2027 * 31.9x
Enterprise Value 57.01B 51.94B 48.08B 43.49B 81.59B 5,324B 85.39B 581B 231B 2,877B 214B 209B 9,113B EV / Sales 2026 *
8.37x
EV / Sales 2027 * 7.41x
Free-Float
86.54%
Yield 2026 *
-
Yield 2027 * -
1 day-1.28%
1 week-1.82%
Current month+12.90%
1 month+19.95%
3 months+14.18%
6 months+26.08%
Current year+21.85%
1 week 103.07
Extreme 103.0683
108
1 month 87.06
Extreme 87.06
108
Current year 74.66
Extreme 74.66
108
1 year 74.66
Extreme 74.66
108
3 years 58.93
Extreme 58.93
108
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 2023-05-10
Director of Finance/CFO 43 2026-05-28
Chief Tech/Sci/R&D Officer 51 2025-08-31
Director TitleAgeSince
Chairman 69 2024-05-06
Director/Board Member 62 2015-02-09
Director/Board Member 58 2023-05-10
Date Insider Type Main position Quantity % Market Cap. Importance
10/8/26 Exercice

Executive/Senior Manager

1,857 0.0003%
9/14/26 Tax

Executive/Senior Manager

-568 0.0001%
9/13/26 Tax

Controller/Auditor

-253 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.28%-1.82%+23.61%+55.28% 60.51B
-0.58%-4.04%+19.57%+47.67% 257B
-0.45%-3.29%+0.91%+9.52% 161B
-3.26%-9.41%-25.52%+33.40% 146B
-1.49%-4.74%-56.67%-20.89% 63.26B
-0.05%+0.69%+5.41%-12.43% 53.46B
-1.12%-0.91%+21.90%+54.96% 49.99B
-5.15%-13.73%-3.95%+48.93% 44.88B
-2.06%-3.06%+21.20%+74.31% 45.81B
-2.12%-0.86%+15.31%+12.18% 37.83B
Average -0.95%-2.93%+2.18%+30.29% 92B
Weighted average by Cap. -0.77%-3.74%+2.23%+31.34%

Financials

2026 *2027 *
Net sales 6.81B 6.2B 5.74B 5.2B 9.75B 636B 10.2B 69.43B 27.54B 344B 25.55B 25.01B 1,089B 7.48B 6.82B 6.31B 5.71B 10.71B 699B 11.2B 76.26B 30.25B 377B 28.06B 27.47B 1,196B
Net income 1.34B 1.23B 1.13B 1.03B 1.92B 126B 2.01B 13.71B 5.44B 67.86B 5.04B 4.94B 215B 1.86B 1.69B 1.57B 1.42B 2.66B 173B 2.78B 18.93B 7.51B 93.71B 6.97B 6.82B 297B
Net Debt -3.5B -3.19B -2.95B -2.67B -5.01B -327B -5.24B -35.69B -14.16B -177B -13.13B -12.86B -560B -5.08B -4.62B -4.28B -3.87B -7.26B -474B -7.6B -51.74B -20.52B -256B -19.04B -18.64B -811B
Projected Income Statement - Annual - Edwards Lifesciences Corporation
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
26-11-19 $103.88 -1.28% 3,656,478
26-11-18 $105.23 -0.19% 3,923,271
26-11-17 $105.43 -1.57% 4,272,484
26-11-16 $107.11 -0.04% 4,544,597
26-11-13 $107.15 +1.28% 3,822,379
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Edwards Lifesciences Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
103.88USD
Average target price
113.83USD
Spread / Average Target
+9.58%